FDA GCP Inspection Trends Identified Using AI

FDA GCP Inspection Trends Identified Using AI
Presented Tuesday, June 14, 2022
Watch this informative 1-hour presentation with insights into FDA GCP inspection trends, including intelligence on data integrity and clinical investigator enforcement activity.
Speakers:
Jerry Chapman, Redica Systems
Fran Lambetecchio, Regulatory Associates
What is covered:
- Importance and challenges of human clinical studies
- Data sources and evaluation using AI Tools
- What we can learn from US FDA Inspections of Clinical Investigators
- A deeper dive into FDA Warning Letters and 483 data with some surprises